These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8935176)

  • 1. Molecular modelling of beta turns in a cyclic melanotropin.
    Chan NC; Branch SK; Moss SH; Pouton CW
    J Pharm Pharmacol; 1996 Feb; 48(2):218-22. PubMed ID: 8935176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
    Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
    J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics.
    Al-Obeidi F; Castrucci AM; Hadley ME; Hruby VJ
    J Med Chem; 1989 Dec; 32(12):2555-61. PubMed ID: 2555512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists.
    Haskell-Luevano C; Sawyer TK; Trumpp-Kallmeyer S; Bikker JA; Humblet C; Gantz I; Hruby VJ
    Drug Des Discov; 1996 Dec; 14(3):197-211. PubMed ID: 9017363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
    Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
    Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor.
    Yang Yk; Dickinson C; Haskell-Luevano C; Gantz I
    J Biol Chem; 1997 Sep; 272(37):23000-10. PubMed ID: 9287296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor binding affinities and biological activities of linear and cyclic melanocortins in B16 murine melanoma cells expressing the native MC1 receptor.
    Sahm UG; Olivier GW; Branch SK; Moss SH; Pouton CW
    J Pharm Pharmacol; 1996 Feb; 48(2):197-200. PubMed ID: 8935171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocortins and cardiovascular regulation.
    Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
    Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat.
    Adan RA; Szklarczyk AW; Oosterom J; Brakkee JH; Nijenhuis WA; Schaaper WM; Meloen RH; Gispen WH
    Eur J Pharmacol; 1999 Aug; 378(3):249-58. PubMed ID: 10493100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors.
    Haskell-Luevano C; Holder JR; Monck EK; Bauzo RM
    J Med Chem; 2001 Jun; 44(13):2247-52. PubMed ID: 11405661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of new small cyclic melanocortin receptor-binding peptides using molecular modelling: Role of the His residue in the melanocortin peptide core.
    Prusis P; Muceniece R; Mutule I; Mutulis F; Wikberg JE
    Eur J Med Chem; 2001 Feb; 36(2):137-46. PubMed ID: 11311745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
    Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
    J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of the melanocortin 4 receptor by radioligand binding.
    Schiöth HB; Muceniece R; Wikberg JE
    Pharmacol Toxicol; 1996 Sep; 79(3):161-5. PubMed ID: 8884876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographical modification of melanotropin peptide analogues with beta-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activities.
    Haskell-Luevano C; Boteju LW; Miwa H; Dickinson C; Gantz I; Yamada T; Hadley ME; Hruby VJ
    J Med Chem; 1995 Nov; 38(23):4720-9. PubMed ID: 7473600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of conformational isomerism in alpha-melanocyte stimulating hormone by design of cyclic analogues.
    Nikiforovich GV; Sharma SD; Hadley ME; Hruby VJ
    Biopolymers; 1998 Sep; 46(3):155-67. PubMed ID: 9699465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective properties of C- and N-terminals and core residues of the melanocyte-stimulating hormone on binding to the human melanocortin receptor subtypes.
    Schiöth HB; Mutulis F; Muceniece R; Prusis P; Wikberg JE
    Eur J Pharmacol; 1998 May; 349(2-3):359-66. PubMed ID: 9671118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues.
    Labbé O; Desarnaud F; Eggerickx D; Vassart G; Parmentier M
    Biochemistry; 1994 Apr; 33(15):4543-9. PubMed ID: 8161509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I beta-turn conformation is important for biological activity of the melanocyte-stimulating hormone analogues.
    Li SZ; Lee JH; Lee W; Yoon CJ; Baik JH; Lim SK
    Eur J Biochem; 1999 Oct; 265(1):430-40. PubMed ID: 10491201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.